PharmiWeb.com - Global Pharma News & Resources
04-Jul-2019

Atorvastatin API Market Worth USD 4,25,804.16 Thousand By 2023 with Steady CAGR: 3.34%

Global Atorvastatin API Market is expected to register a CAGR of 3.34% to reach USD 4,25,804.16 thousand by 2023.

The Global Atorvastatin API Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2017 to 2023. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2017 to 2023.

We can provide sample pages for a better understanding of this report.
Request Sample of This Report @ http://www.amecoresearch.com/sample/12950

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the Global Atorvastatin API Market.

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market.

The market is studied for regions such as North America (U.S., and Canada), Europe (U.K., Germany, France, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East amp; Africa (GCC, South Africa, and Rest of Middle East amp; Africa).

Key Takeaways:

What is the market size in 2018 and the growth rate of the Global Atorvastatin API Market?

What is the market drivers, restrains, opportunities governing the Global Atorvastatin API Market?

Which are the largest and the fastest growing segments in the Global Atorvastatin API Market?

Who are the key players operating in the market and their market position?

What is the pipeline scenario, drug pricing analysis and technological development in the market?

View Detail Report With Complete Table Of Content@ http://www.amecoresearch.com/market-report/atorvastatin-api-market-mrf-12950

Global Atorvastatin API Market: Information by Application (Hypercholesterolemia, Hypertriglyceridemia, Dyslipidemia and others) and Region (North America, Europe, Asia-Pacific and the Middle East amp; Africa) - Forecast till 2023

Market Overview

The Global Atorvastatin API Market is expected to register a CAGR of 3.34% to reach USD 4,25,804.16 thousand by 2023. Atorvastatin belongs to the group of medicines known as statins, also called as the HMG-CoA reductase inhibitors. HMG-CoA reductase is an enzyme involved in varying and maintaining the cholesterol levels in the body. Atorvastatin is mainly used to prevent vital cardiovascular occasions and lower total and bad cholesterol (LDL-cholesterol) and triglyceride levels in the blood.

The high adoption of atorvastatin in the treatment of cardiovascular diseases is expected to drive the market growth. However, adverse health effects associated with atorvastatin are likely to restrain market growth.

Market Dynamics

The Global Atorvastatin API Market has been largely benefited by the rising adoption of atorvastatin in the treatment of cardiovascular diseases. Additionally, the growing prevalence of dyslipidemia in China provides opportunities for growth in the market. However, adverse health effects associated with atorvastatin is expected to restrain market growth.
Segmentation

The hypercholesterolemia segment is expected to lead the market and register a substantial CAGR to reach USD 2,10,753.23 thousand by the end of 2023. High prevalence of hypercholesterolemia is expected to drive the market growth. Additionally, the segment is projected to exhibit the highest CAGR of 4.09% from 2018 to 2023.

Key Players

The prominent players in the Global Atorvastatin API Market are Teva Pharmaceutical Industries Ltd (Israel), Jubilant Life Sciences Ltd (India), Dr. Reddyrsquo;s Laboratories Ltd (India), Sun Pharmaceutical Industries Ltd (India), Ind-Swift Labs Ltd (India), Morepen Laboratories Ltd (India), Zhejiang Hisun Pharmaceutical Co Ltd (China), Anuh Pharma Ltd (India), Centrient Pharmaceuticals (The Netherlands) and Cadila Pharmaceuticals (India).

The players operating in the Global Atorvastatin API Market are focusing on product launches, along with expanding their global footprints by entering untapped markets.

Regional Analysis

North America accounted for the largest market share of 40.64% in 2017, and the regional market is projected to register a CAGR of 3.10% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The Chinese market is projected to exhibit the highest growth rate of 5.86% during the forecast period from 2018 to 2023.

The European market is estimated to exceed USD 1,31,094.04 thousand by 2023. High prevalence of hypercholesterolemia and mixed dyslipidemia are driving the growth of the Atorvastatin API market in the region. France is the major contributor to the growth of the regional market, followed by the UK.

Market Segmentation

Global Atorvastatin API Market, by Application
Hypercholesterolemia
Hypertriglyceridemia
Dyslipidemia
Others

Global Atorvastatin API Market, by Region
North America
US
Canada
Latin America
Europe
Germany
UK
France
Spain
Italy
Eastern Europe
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Middle East amp; Africa
Middle East
Africa

Available Additional Customizations
Challenges in the market
Macroeconomic Indicators of the Global Atorvastatin API Market

Intended Audience
Atorvastatin API Manufacturers
Pharmaceutical Companies
Contract Research Organizations
Contract Manufacturing Organizations

Few Important Points From Table Of Contents

Atorvastatin API Market Research Report - Global Forecast till 2023

1 Executive Summary
2 Market Introduction
3 Research Methodology
4 Market Dynamics
5 Market Factor Analysis
6 Global Atorvastatin API Market, by Application
7 Global Atorvastatin API Market, by Region
8 Competitive Landscape
9 Company Profiles
10 Conclusion

Quick Buy This Premium Report From Here: http://www.amecoresearch.com/buy/12950

About Us:

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact:

Email: sales@amecoresearch.com | +1 407 915 4157

Editor Details

Last Updated: 04-Jul-2019